Table 2

Schedule of assessments in the trial

TaskScreeningRandomisationBaselineDays 1–28180-day
follow-up
Assess eligibility to enter studyX    
Assess ability to gain consent and follow-upX    
ConsentX    
Demographics and eligibility checklistXXX  
Laboratory data  XX 
Vital signs  XX 
Vital status up to day 28 in the ICU   XX
Vital and functional status    X
Discharge date from ICU, from hospital   XX
Adverse events   X 
Protocol violations   X 

  • ICU, intensive care unit.